Cargando…

Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries

INTRODUCTION: Although there is a significant utilization gap of biologic medicines in the EU, many studies estimate equity in patient access to biopharmaceuticals only based on their availability on the national list of reimbursed medicines. Hidden access barriers may facilitate financial sustainab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inotai, András, Tomek, Dominik, Niewada, Maciej, Lorenzovici, László, Kolek, Martin, Weber, Jakub, Kurrat, Anne-Katrin, Kiss, Emese Virág, Kaló, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291365/ https://www.ncbi.nlm.nih.gov/pubmed/32581804 http://dx.doi.org/10.3389/fphar.2020.00845

Ejemplares similares

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
por: Inotai, Andras, et al.
Publicado: (2018)

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
por: Inotai, András, et al.
Publicado: (2012)

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges
por: Daubner-Bendes, Rita, et al.
Publicado: (2021)

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
por: Jakab, Ivett, et al.
Publicado: (2023)

Burden of Chronic Heart Failure in Romania
por: Lorenzovici, László, et al.
Publicado: (2022)

Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe
por: Golicki, Dominik, et al.
Publicado: (2019)

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making
por: Németh, Bertalan, et al.
Publicado: (2023)

Overview on Patient Centricity in Cancer Care
por: Narbutas, Šarunas, et al.
Publicado: (2017)

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings
por: Petykó, Zsuzsanna Ida, et al.
Publicado: (2021)

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
por: Kaló, Zoltán, et al.
Publicado: (2021)

Riding the Pandemic Waves—Lessons to Be Learned from the COVID-19 Crisis Management in Romania
por: Túri, Gergő, et al.
Publicado: (2022)

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
por: McQueen, R. Brett, et al.
Publicado: (2022)

Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
por: Lorenzovici, László, et al.
Publicado: (2023)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018)

Proposal for capturing patient experience through extended value frameworks of health technologies
por: Inotai, András, et al.
Publicado: (2021)

The EEC at the end of the seventies : Western European integration in the new world economic environment /
por: Inotai, András
Publicado: (1979)

Polymorphisms of tumor necrosis factor alpha in Middle Eastern population with colorectal cancer
por: Hamadien, Maha-Abdulla, et al.
Publicado: (2015)

EQ-5D-5L Polish population norms
por: Golicki, Dominik, et al.
Publicado: (2015)

REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE
por: Mandrik, Olena, et al.
Publicado: (2015)

Cost-of-illness studies in nine Central and Eastern European countries
por: Brodszky, Valentin, et al.
Publicado: (2019)

HTA Implementation Roadmap in Central and Eastern European Countries
por: Kaló, Zoltán, et al.
Publicado: (2016)

Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
por: Zelei, Tamás, et al.
Publicado: (2016)

Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
por: Incze, András, et al.
Publicado: (2022)

Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
por: Tomek, Jakub, et al.
Publicado: (2019)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
por: Vokó, Zoltán, et al.
Publicado: (2012)

Toxicity mitigation by N-acetylcysteine and synergistic toxic effect of nano and bulk ZnO to Panagrellus redivivus
por: Kiss, Lola Virág, et al.
Publicado: (2021)

Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review
por: Ágh, Tamás, et al.
Publicado: (2015)

Delayed payment schemes in Central-Eastern Europe and Middle-East
por: Ádám, Ildikó, et al.
Publicado: (2022)

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
por: Kawalec, Paweł, et al.
Publicado: (2017)

Cost Assessment of Inpatient Care Episodes of Stroke in Romania
por: Lorenzovici, László, et al.
Publicado: (2020)

Medical and economic burden of influenza in the elderly population in central and eastern European countries
por: Kovács, Gábor, et al.
Publicado: (2014)

Anti-Tumor Necrosis Factor Alpha for Retinal Diseases: Current Knowledge and Future Concepts
por: Mirshahi, Alireza, et al.
Publicado: (2012)

Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus.
por: Torzecka, Jolanta Dorota, et al.
Publicado: (2003)

How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington’s Disease? A Comprehensive Review
por: Lontay, Beata, et al.
Publicado: (2020)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Additives Enhancing the Catalytic Properties of Lipase from Burkholderia cepacia Immobilized on Mixed-Function-Grafted Mesoporous Silica Gel
por: Abaházi, Emese, et al.
Publicado: (2014)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
por: Zemplényi, Antal, et al.
Publicado: (2023)

Examination of the diaphragm in obstructive sleep apnea using ultrasound imaging
por: Molnár, Viktória, et al.
Publicado: (2021)

TmAlphaFold database: membrane localization and evaluation of AlphaFold2 predicted alpha-helical transmembrane protein structures
por: Dobson, Laszlo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ipgfj4pjinoa8p6v8csviqs7ss